(Q83548592)

English

Re-circulation of lymphocytes mediated by sphingosine-1-phosphate receptor-1 contributes to resistance against experimental infection with the protozoan parasite Trypanosoma cruzi

scientific article published on 28 February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22381075%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Re-circulation of lymphocytes mediated by sphingosine-1-phosphate receptor-1 contributes to resistance against experimental infection with the protozoan parasite Trypanosoma cruzi (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22381075%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

experimental infection

1 reference

based on heuristic

inferred from title

Trypanosoma cruzi

object named as

Trypanosoma cruzi

1 reference

based on heuristic

inferred from title

Mariana R Dominguez

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22381075%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Jonatan Ersching

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22381075%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Oscar Bruna-Romero

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22381075%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

Ramon Lemos

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22381075%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Alexandre V Machado

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22381075%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Mauricio M Rodrigues

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22381075%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

José Ronnie C de Vasconcelos

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22381075%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

28 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22381075%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22381075%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22381075%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22381075%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

2882-2891

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22381075%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Immune system recognition of Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Trypanosoma cruzi infection from the view of CD8+ T cell immunity--an infection model for developing T cell vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

CD8+ T cells in Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans-sialidase

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural CD4+ T-cell responses against Trypanosoma cruzi KMP-11 protein in chronic chagasic patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Modulation of CD4(+) T cell-dependent specific cytotoxic CD8(+) T cells differentiation and proliferation by the timing of increase in the pathogen load

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Infection with Trypanosoma cruzi restricts the repertoire of parasite-specific CD8+ T cells leading to immunodominance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Stable CD8+ T cell memory during persistent Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Trypanosoma cruzi subverts host cell sialylation and may compromise antigen-specific CD8+ T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Immunodominance: a new hypothesis to explain parasite escape and host/parasite equilibrium leading to the chronic phase of Chagas' disease?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Protective Immunity Against Trypanosoma cruzi Infection in a Highly Susceptible Mouse Strain After Vaccination with Genes Encoding the Amastigote Surface Protein-2 and Trans-Sialidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Redirection of the immune response to the functional catalytic domain of the cystein proteinase cruzipain improves protective immunity against Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Egress: a receptor-regulated step in lymphocyte trafficking

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Subdominant/cryptic CD8 T cell epitopes contribute to resistance against experimental infection with a human protozoan parasite.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Insufficient TLR activation contributes to the slow development of CD8+ T cell responses in Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Requirement of secondary lymphoid tissues for the induction of primary and secondary T cell responses against Listeria monocytogenes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Leishmania (Leishmania) amazonensis infection in mice treated with FTY720.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Preservation of functional virus-specific memory CD8+ T lymphocytes in vaccinated, simian human immunodeficiency virus-infected rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Anti-inflammatory effects of FTY720 against viral-induced immunopathology: role of drug-induced conversion of T cells to become Foxp3+ regulators

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.037

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.02.037

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22381075%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22381075%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83548592&oldid=1799837628"